BAILLIE GIFFORD & CO 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 24,864,058 6.500% | 11,706,364 (+88.97%) | Filing |
| 2025-02-12 06:24 am Sale | 2024-12-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 13,157,694 6.600% | -50,208,614 (-79.24%) | Filing |
| 2024-11-05 07:51 am Purchase | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 63,366,308 5.200% | 47,795,973 (+306.97%) | Filing |
| 2024-11-05 07:49 am Purchase | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 15,570,335 7.800% | 10,131,215 (+186.27%) | Filing |
| 2024-11-04 10:15 am Sale | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 5,439,120 5.600% | -19,800,750 (-78.45%) | Filing |
| 2024-11-04 09:46 am Purchase | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 25,239,870 9.200% | 18,698,991 (+285.88%) | Filing |
| 2024-11-04 09:44 am Purchase | 2024-09-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 6,540,879 14.500% | 633,574 (+10.73%) | Filing |
| 2024-01-29 09:55 am Sale | 2023-12-29 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 5,907,305 14.590% | -197,111 (-3.23%) | Filing |
| 2023-01-23 11:31 am Purchase | 2022-12-30 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 6,104,416 18.030% | 1,910,599 (+45.56%) | Filing |
| 2022-02-03 11:29 am Purchase | 2022-01-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 2,971,890 10.000% | 235,636 (+8.61%) | Filing |
| 2022-01-20 06:20 am Purchase | 2021-12-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | BAILLIE GIFFORD & CO | 2,736,254 9.210% | 2,736,254 (New Position) | Filing |